drugset / Trial / NCT01468714
A Study To Estimate The Effect Of Ketoconazole On The Pharmacokinetics Of Pf-04937319 In Healthy Subjects
NaSingle-groupOpen-labelBasic science
Summary
This study will evaluate the potential for a drug-drug interaction of PF-04937319 with ketoconazole, a potent inhibitor of the drug metabolizing enzyme CYP3A.
Timeline
- Start
- 2011-10
- Primary completion
- 2011-10
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketoconazole | Small molecule | 200 mg | — |
| Subject | NERIGLIATIN | Small molecule | 20 mg | — |
Indications
No indication recorded.